Tumor-specific Th1 cells are known to provide essential help to CD8+ T cells to kill cancer cells, and have also been reported to suppress tumor development by inhibiting angiogenesis and by inducing the tumoricidal activity of macrophages (9, 10, 20). Here, CD8A is linked to neoplasm.